125 related articles for article (PubMed ID: 4548844)
1. Cancer immunotherapy--dream or reality?
Nossal GJ
Aust J Ophthalmol; 1973 Oct; 1(3):95-100. PubMed ID: 4548844
[No Abstract] [Full Text] [Related]
2. [A scientist's day-dream or future reality? Specific immunotherapy against cancer].
Kiessling R; Kärre K
Lakartidningen; 1997 Apr; 94(17):1595-600. PubMed ID: 9182159
[No Abstract] [Full Text] [Related]
3. Progress in human tumour immunology and immunotherapy.
Rosenberg SA
Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
[TBL] [Abstract][Full Text] [Related]
4. [Cancer immunotherapy: immunologic bases, reality and hopes].
Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
[TBL] [Abstract][Full Text] [Related]
5. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
6. Cancer immunotherapy.
Falk RE
Can Med Assoc J; 1979 Feb; 120(3):255, 258. PubMed ID: 311678
[No Abstract] [Full Text] [Related]
7. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
8. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
9. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
11. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
12. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
13. [Effect of immune processes on the growth and regression of malignant tumors].
Russo V; Russo L
Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
[No Abstract] [Full Text] [Related]
14. Immunology in tumor therapeutics: an overview.
Barber HR
Del Med J; 1980 Apr; 52(4):197-209. PubMed ID: 6153996
[No Abstract] [Full Text] [Related]
15. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.
Neeson P; Paterson Y
Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy of cancer (some immunological problems in cancer therapy)].
Izumi T
Bull Chest Dis Res Inst Kyoto Univ; 1973 Dec; 7(1):58-65. PubMed ID: 4135979
[No Abstract] [Full Text] [Related]
17. Cancer vaccines: pessimism in check.
Mocellin S; Mandruzzato S; Bronte V; Marincola FM
Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
[No Abstract] [Full Text] [Related]
18. Immunology and cancer.
Marchalonis J
Adv Pathobiol; 1976; 2():38-45. PubMed ID: 1088245
[No Abstract] [Full Text] [Related]
19. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
[No Abstract] [Full Text] [Related]
20. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
